发明名称 |
Pharmaceutical composition comprising a compound having anti-xa activity and a platelet aggregation antagonist compound |
摘要 |
The invention is also directed to pharmaceutical composition comprising a compound having anti-Xa activity, a platelet aggregation antagonist compound and a pharmaceutically acceptable carrier. The invention is also directed to a method of treating or preventing a thrombogenic condition associated with a thrombosis related ischemic disorder in a patient comprising administering to said patient pharmaceutically effective amounts of a compound having anti-Xa activity and a platelet aggregation antagonist compound. In addition, this invention is directed to the use of pharmaceutically effective amounts of a compound having anti-Xa activity and a platelet aggregation antagonist compound in the preparation of a medicament for treating or preventing a physiological condition associated with thrombosis related ischemic disorder. Furthermore, this invention is directed to a kit for treating or preventing a physiological condition associated with thrombosis related ischemic disorder, said kit comprising a plurality of separate containers, wherein at least one of said containers contains a compound having anti-Xa activity and at least another of said containers contains a platelet aggregation antagonist compound, and said containers optionally contain a pharmaceutical carrier.
|
申请公布号 |
US2002032214(A1) |
申请公布日期 |
2002.03.14 |
申请号 |
US20000516981 |
申请日期 |
2000.03.01 |
申请人 |
UZAN ANDRE;CURAUDEAU ALAIN H;LEADLEY ROBERT J;DUNWIDDIE CHRISTOPHER T;PERRONE MARK H |
发明人 |
UZAN ANDRE;CURAUDEAU ALAIN H;LEADLEY ROBERT J;DUNWIDDIE CHRISTOPHER T;PERRONE MARK H |
分类号 |
A61K45/00;A01N43/42;A61K31/44;A61K31/445;A61K31/715;A61K31/727;A61K38/00;A61K38/05;A61K39/395;A61K39/40;A61K39/42;A61P7/02;A61P9/10;A61P35/00;(IPC1-7):A61K31/44 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|